Precision BioSciences Inc. (DTIL:NSQ) swings up 17% on stock market in one day

0Comments

Precision BioSciences Inc. (DTIL:NSQ) saw one of the biggest daily changes on Wall Street, up 17 percent throughout the day.

It rose $0.26, placing it 30th among the top 50 biggest swings in Wall Street during the time frame.

Shares in Precision BioSciences Inc. finished on June 3 at $1.79.

Precision BioSciences Inc. employs 190 people and has reported -$40,080,000 USD in income.

Stock fluctuations are affected by several factors, from news about the company involved to global trade difficulties or successes.

Despite a tumultuous year with the COVID-19 pandemic, the US stock market overall remained strong in 2021.

Tony Despirito at investment firm BlackRock said “Overall, companies have beat analyst expectations on both earnings per share and revenue growth. But the latter has been particularly strong.”

Nothing in this article is to be assumed as financial advice.

Top 50 biggest stock market swings on June 3

Company Name Percentage Change Current Trading Price
Turning Point Therapeutics Inc. 118.4% $74.59
Golden Star Resource Corp. 98% $2
Kinetic Group Inc. 75.4% $2.28
Balincan International Inc. 66.4% $3.61
Blue Dolphin Energy Co. 51.2% $1.89
Energy Focus Inc. 48.6% $1.65
Yumanity Therapeutics Inc. 34% $1.42
Rapid Therapeutic Science Laboratories Inc. 32.7% $3
Rallybio Corp. -30% $9.26
Houston American Energy Corp. 27.5% $5.65
Rayont Inc. 25% $1
Applied Energetics Inc. 24.9% $3.06
Harpoon Therapeutics Inc. 21.2% $2.4
AudioEye Inc. 20.4% $4.07
Neuroone Medical Technologies Corp. -20.4% $1.09
Greenbox Pos 20.3% $2.55
Cortexyme Inc. 20.1% $3.17
Novavax Inc. -20% $44.76
Rubius Therapeutics Inc. 20% $1.11
Sprague Resources LP 19.6% $18.93
Joann Inc. -19.5% $6.36
Sow Good Inc. 19.5% $3
Bellicum Pharmaceuticals Inc. -19.2% $1.18
Iovance Biotherapeutics Inc. 18.9% $7.85
Puma Biotechnology Inc. 18.2% $2.34
Curiositystream Inc. 17.8% $1.79
Gain Therapeutics Inc. 17.8% $3.5
Hashicorp Inc. -17.6% $34
Farmhouse Inc. 17.3% $1.49
Precision BioSciences Inc. 17% $1.79
IN8BIO, Inc. 16.7% $2.65
Nine Energy Service Inc. 16.7% $3.92
Everything Blockchain Inc. -16.7% $2.4
TraqIQ Inc. 16.7% $3.5
FalconStor Software Inc. 16.5% $1.2
Verrica Pharmaceuticals Inc. 16.4% $2.27
Nurix Therapeutics Inc. 16.3% $10.57
Olema Pharmaceuticals Inc. 16.3% $3.36
Beyondspring Inc. 16.1% $1.59
Oric Pharmaceuticals Inc. 15.9% $3.8
Invitae Corp. -15.2% $3.02
Qurate Retail Inc. 14.9% $5.08
Pear Therapeutics Inc. 14.8% $4.34
Winc Inc. -14.8% $2.13
Invacare Corp. 14.7% $1.17
Digital Media Solutions Inc. 14.6% $1.81
Greenwich Lifesciences Inc. 14.3% $9.01
Annexon Inc. 14.2% $3.38
Rxsight Inc. 14.2% $16
Atreca Inc. 14.1% $1.78


Related

Craig T. Albanese, CEO

Duke Health trial finds immunotherapy delays chemotherapy in advanced colorectal cancer

A new clinical trial from Duke Health shows that first-line immunotherapy may delay or replace chemotherapy in advanced colorectal cancer cases. The findings offer hope for improved quality of life among younger patients facing aggressive forms of the disease.

Hannah Lohman, RTI Research Environmental Engineer

EPA and HHS announce actions to address microplastics in drinking water

The EPA and HHS have announced new efforts targeting microplastics in U.S. drinking water systems. RTI International staff attended as federal officials detailed regulatory plans prioritizing research funding into detection methods, impacts on health, prevention strategies, and laboratory standards.

Tim J. Gabel, President and Chief Executive Officer

RTI International examines trends and shifts in ultra-processed food consumption

RTI International highlights rising consumer awareness about ultra-processed foods (UPFs) alongside industry reformulations and emerging state-level policies restricting certain additives. The organization points out challenges surrounding inconsistent definitions while noting increased calls for transparency from both regulators and public health advocates.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Durham Reporter.